Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Del Poeta

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
American Journal of Clinical Pathology|January 14, 1998
A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemiasM C Cox, L Maffei, S Buffolino, et al.
Leukemia & Lymphoma|January 1, 1995
Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot studyA Venditti, M T Scimò, G del Poeta, et al.
Blood|January 1, 1996
Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-M0) and its clinical implicationsA Venditti, G Del Poeta, R Stasi, et al.
Haematologica|September 1, 1994
Diagnosis of acute myeloid leukemia and system Coulter VCSA Bruno, G Del Poeta, A Venditti, et al.
Annals of Hematology|July 1, 1995
Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemiaR Stasi, C G Taylor, A Venditti, et al.
Blood|March 1, 1996
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemiaG Del Poeta, R Stasi, G Aronica, et al.
Annals of Hematology|May 10, 2000
A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromesA Venditti, A Tamburini, F Buccisano, et al.
Leukemia|November 9, 2013
CD49d expression identifies a chronic-lymphocytic leukemia subset with high levels of mobilized circulating CD34(+) hemopoietic progenitors cellsF M Rossi, A Zucchetto, E Tissino, et al.
Blood|January 1, 1997
Biological pattern of AML-M0 versus AML-M1: responseA Venditti, G Del Poeta, F Buccisano, et al.
Journal of Internal Medicine|August 1, 1997
Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia veraR Stasi, M Brunetti, S Bussa, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
American Journal of Clinical Pathology|January 14, 1998
A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemiasM C Cox, L Maffei, S Buffolino, et al.
Leukemia & Lymphoma|January 1, 1995
Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot studyA Venditti, M T Scimò, G del Poeta, et al.
Blood|January 1, 1996
Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-M0) and its clinical implicationsA Venditti, G Del Poeta, R Stasi, et al.
Haematologica|September 1, 1994
Diagnosis of acute myeloid leukemia and system Coulter VCSA Bruno, G Del Poeta, A Venditti, et al.
Annals of Hematology|July 1, 1995
Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemiaR Stasi, C G Taylor, A Venditti, et al.
Blood|March 1, 1996
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemiaG Del Poeta, R Stasi, G Aronica, et al.
Annals of Hematology|May 10, 2000
A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromesA Venditti, A Tamburini, F Buccisano, et al.
Leukemia|November 9, 2013
CD49d expression identifies a chronic-lymphocytic leukemia subset with high levels of mobilized circulating CD34(+) hemopoietic progenitors cellsF M Rossi, A Zucchetto, E Tissino, et al.
Blood|January 1, 1997
Biological pattern of AML-M0 versus AML-M1: responseA Venditti, G Del Poeta, F Buccisano, et al.
Journal of Internal Medicine|August 1, 1997
Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia veraR Stasi, M Brunetti, S Bussa, et al.
Pageof 9